COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,313 Articles (22,772 medRxiv, 8,541 bioRxiv)

Most recent first Previous |  Page 1093: Articles 10921-10930  | Next

Using patient biomarker time series to determine mortality risk in hospitalised COVID-19 patients: a comparative analysis across two New York hospitals
Lambert, B., Stopard, I., Momeni-Boroujeni, A., Mendoza, R., Zuretti, A.
10.1101/2021.11.12.21266248 — Posted: 2021-12-08
Proactive vs. reactive country responses to the COVID19 pandemic shock
Sacco, P., Valle, F., De Domenico, M.
10.1101/2021.12.06.21267351 — Posted: 2021-12-07
Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection
Evans, J. P., Zeng, C., Carlin, C., Lozanski, G., Saif, L. J., Oltz, E. M., Gumina, R. J., Liu, S.-L.
10.1101/2021.12.06.471455 — Posted: 2021-12-07
Engineering RNA viruses with unnatural amino acid to evoke adjustable immune response in mice
Zheng, Z., Wang, Y., Wu, X., Zhang, H., Chen, H., Lin, H., Shen, Y., Xia, Q.
10.1101/2021.12.04.471206 — Posted: 2021-12-07
The Impact of Mass Exodus on the Resurgence of COVID19 Cases: Study Case of Regions in Indonesia
Nuraini, N., Sukandar, K. K., Aini, W.
10.1101/2021.12.06.21267391 — Posted: 2021-12-07
Systematic review of cardiac adverse effects in children and young people un-der 18 years of age after SARS-CoV-2 vaccination
Cruz, J., Duret, A., Harwood, R., Fraser, L. K., Jones, C. B., Ward, J., Whittaker, E., Kenny, S. E., Vinner, R. M.
10.1101/2021.12.06.21267339 — Posted: 2021-12-07
Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
Li, D., Cheng, S., Debbas, P., Braun, J., McGovern, D. P. B., Melmed, G. Y., CORALE-IBD Study Group
10.1101/2021.12.05.21266089 — Posted: 2021-12-07
Facilitating safe discharge through predicting disease progression in moderate COVID-19: a prospective cohort study to develop and validate a clinical prediction model in resource-limited settings
Chandna, A., Mahajan, R., Gautam, P., Mwandigha, L., Gunasekaran, K., Bhusan, D., Cheung, A. T. L., Day, N., Dittrich, S., Dondorp, A., Geevar, T., Ghattamaneni, S. R., Hussain, S., Jimenez, C., Karthikeyan, R., Kumar, S., Kumar, S., Kumar, V., Kundu, D., Lakshmanan, A., Manesh, A., Menggred, C., Moorthy, M., Osborn, J., Richard-Greenblatt, M., Sharma, S., Singh, V. K., Singh, V. K., Suri, J., Suzuki, S., Tubprasert, J., Turner, P., Villanueva, A. M. G., Waithira, N., Kumar, P., Varghese, G. M., Koshiaris, C., Lubell, Y., Burza, S.
10.1101/2021.12.02.21267170 — Posted: 2021-12-07
Individual vaccine efficacy variation with time since mRNA BNT162b2 vaccination estimated by rapid, quantitative antibody measurements from a finger-prick sample.
Vargas, M. J., Chandrasekhar, M., Kwon, Y. J., Deijs, G. S., Corazza, C. M. O. W., Chai, A., Binedell, R. L., Jose, E., Govind, B., Huyet, L., Patel, P. K., Reshef, G., Kumar, V., Lowe, T., Powell, R. J., Jina, K. C., Walker, F. C. W., Talemaitoga, A., Simpson, M. C., Williams, D. E.
10.1101/2021.11.30.21267102 — Posted: 2021-12-07
A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing
Savage, H. R., Finch, L., Body, R., Watkins, R. L., LSTM Diagnostics Group, , CONDOR steering group, , Hayward, G., Cook, E., Cubas Atienzar, A. I., Cuevas, L., MacPherson, P., Adams, E. R.
10.1101/2021.12.06.21267356 — Posted: 2021-12-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).